Compare Regeneron Pharmaceuticals Inc (REGN) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Tractor Supply Co — how do they compare? Regeneron Pharmaceuticals Inc trades at $745.9 (market cap $76.14B), while Tractor Supply Co trades at $33.5 (market cap $17.44B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 4.4× Tractor Supply Co's market cap, and Tractor Supply Co pays the higher dividend (2.87%). Which is the better fit depends on your goals — on Pluang, investors hold Regeneron Pharmaceuticals Inc for 107 Days and Tractor Supply Co for 88 Days on average.
| REGN | TSCO | |
|---|---|---|
Market Cap | $76.14B | $17.44B |
Volume | 500,239 | 10,598,723 |
Sector | Health | Consumer Cyclical |
52-Week High | $852.03 | $56.37 |
52-Week Low | $557.73 | $29.14 |
Typical Hold Time | 107 Days | 88 Days |
Enterprise Value | $70.85B | $23.76B |
Dividend Yield | 0.51% | 2.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Regeneron Pharmaceuticals (REGN) trades at $739.28, down 0.38% on the day, with a bearish technical signal and neutral oscillators. The company shows strong fundamentals with a P/E of 18.3, net income margin of 27.86%, and consistent earnings beats in recent quarters. Recent news highlights a major $8 billion immunology alliance expansion with Sanofi, including a $1 billion upfront payment, reinforcing its pipeline strength and long-term growth prospects.
The outlook remains positive driven by robust profitability, strategic collaborations, and a bullish analyst consensus with a $849.84 price target. Key risks include competitive pressures in key drug markets and reliance on successful clinical trial outcomes. Institutional sentiment is strong with no sell ratings, supporting a favorable risk-reward profile for investors seeking exposure to biopharmaceutical innovation.
Tractor Supply (TSCO) trades at $32.52, up 0.71% today, with a bullish technical signal from moving averages. The company reported revenue growth to $15.52B in 2025, but net income margin has declined to 6.42%, and it missed earnings estimates for three consecutive quarters. Recent news highlights community initiatives and a new distribution center opening, while some institutional investors reduced positions.
Outlook is mixed: analyst consensus is a Buy with a $36.76 price target, but earnings misses and margin pressure pose risks. The dividend streak remains a positive, yet competitive and cyclical headwinds require monitoring for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
